World
North Korea Warns US Over Nuclear Drills at UN
North Korea has told the United Nations it holds a "legitimate right" to self-defence and accused the United States and South Korea…
Author: <span>Khabar 24h Editorial Desk</span>
Khabar 24h Editorial Desk — our explainers are prepared by the Khabar 24h editorial team using AI-assisted research tools, and every piece is reviewed by a human editor before publishing. We do not claim original reporting: our work is turning complex topics into simple, accurate summaries. Spotted an error? Write to contact@khabar24h.com — our corrections policy aims for same-day review.
Defense & Security
Estonia Blames Russia for Arson at Milrem Defence Firm
Estonia has concluded that an August arson attack on a defence company supplying Ukraine was commissioned by Russian security services, sharply...
Defense & Security
Iran’s IRGC Warns US Bases ‘Will Close’ in Any War
Iran's top navy commander has sent a direct message to Americans, saying US military bases across the region are "illegitimate" and would…
Technology
AI Researchers Warn Labs Racing on Self-Improving Systems
Current and former AI researchers are warning that leading labs are racing toward self-improving AI systems before the world is ready, in…
World
Australia Summons Altman, Amodei Over Medicare AI Breach
Australia's Senate AI inquiry has invited OpenAI chief Sam Altman and Anthropic chief Dario Amodei to appear at a public hearing in…
Health & Wellness
Genflow Completes Canine Healthspan Trial of SIRT6 Therapy
Genflow Biosciences has completed SLAB, its canine healthspan and sarcopenia trial in aged beagle dogs, testing the GF-1004 gene construct based on…
Health & Wellness
MSD Starts Phase 1 Trial of Cyprumed Oral Peptide Tech
Austrian biotech Cyprumed has announced that MSD, the tradename of Merck and Co, has started a Phase 1 clinical trial of a…
Health & Wellness
Invivyd’s Antibody Beats mRNA Vaccine on Safety in Phase 3
Invivyd has announced positive topline results from its LIBERTY Phase 3 study, saying its VYD2311 monoclonal antibody showed safety and tolerability s…
Health & Wellness
Solvonis Claims Alcohol-Disorder Drug Cut Heavy Drinking 67%
Solvonis Therapeutics says a new analysis of its ketamine-based alcohol-use-disorder candidate SVN-001 shows a 67 per cent reduction in heavy-drinking…
Health & Wellness
uniQure Reports 4-Year Data for Huntington’s Gene Therapy
uniQure has reported fresh four-year data for its Huntington's disease gene therapy AMT-130, saying the treatment continues to slow disease progressio…